Redhawk Wealth Advisors, Inc. Edwards Lifesciences Corp Transaction History

Redhawk Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 25, 2022	SELL	$86.5 - $128.27 $907,039 - $1.35 Million	-10,486 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$101.96 - $128.34 $338,711 - $426,345	3,322 Added 46.37%	10,486 $1.23 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $105,731 - $129,895	994 Added 16.11%	7,164 $928,000
Q3 2021 Nov 02, 2021	BUY	$102.91 - $122.75 $634,954 - $757,367	6,170 New	6,170 $699,000
Q1 2020 Apr 14, 2020	SELL	$52.41 - $81.0 $115,668 - $178,767	-2,207 Closed	0 $0

Q4 2019 Feb 25, 2020	BUY	$71.7 - $82.09 $158,241 - $181,172	2,207 New	2,207 $515,000

1,377

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.